gebhart/patrepeval huggingface dataset:
Development of Selective Antagonists against an HIV Second Receptor (2001)

The authors have discovered a highly selective CXCR4 antagonist, T22 ([Tyr5,12, Lys7]-polyphemusin II), and its shortened potent analogs, T140 and TC14012, which strongly inhibit the T-cell line-tropic HIV-1 (X4-HIV-1) infection through their specific binding to a chemokine receptor, CXCR4. CXCR4 is a major coreceptor (second receptor) for the entry of X4-HIV-1 into T-cells. These peptides have been found through the structure-activity relationship (SAR) study on tachyplesins and polyphemusins, which function as self-defense peptides of horseshoe crabs with immature immune systems. T140 and TC14012 showed the highest level of anti-HIV activity and antagonism of target cell entry by X4-HIV-1 among all the CXCR4 antagonists that have been reported to date. Additionally, bifunctional anti-HIV agents based on the specific CXCR4 antagonists (T140 analogs)-3'-azido-3'-deoxythymidine (AZT) conjugation have been synthesized and evaluated, since T140 analogs can possibly work as a carrier of AZT targeting T-cells due to their specific affinity for CXCR4 on T-cells. T22 have two disulfide bonds and a Trp residue in the molecule. In connection with this study, novel facile and side-reaction-free methodologies for disulfide bond formation have been established for the increase of the efficiency of SAR studies. Furthermore, the completely stereocontrolled synthetic process for a couple of (E)-alkene dipeptide isosteres starting from L-amino acid has been established in order to facilitate nonpeptidylation studies on peptide-lead candidates. In this review, the authors wish to summarize our recent research on the development of specific antagonists against the HIV second receptor CXCR4, involving studies on the establishment of efficient methodologies for the facile synthesis of peptides and peptide mimetics.
Factors regulating macrophage production and growth: identity of colony-stimulating factor and macrophage growth factor. (1976)

The activities of a colony-stimulating factor (CSF), which stimulates granulocyte-macrophage colony formation by mouse hemopoietic cells, and macrophage growth factor (MGF), which stimulates proliferation of activated peritoneal macrophages, have been demonstrated by various criteria to reside in the same molecular species. These criteria include occurrence in various sources and copurification of the activities in mouse L-cell-conditioned medium as well as the biological, physicochemical, and antigenic properties of the activities of L-cell-conditioned medium. CSF and MGF activities of L-cell-conditioned medium are ascribable to a glycoprotein of mol wt approximately 60,000 which migrates electrophoretically with alpha-globulin. Human urinary CSF, which also possesses MGF activity, has similar properties and can be neutralized by antiserum to highly purified L-cell medium CSF. A procedure is described for the partial purification of material from L-cell medium that has activity at 1 ng/ml in both MGF and CSF assays.
Trust Enhanced Secure Mobile Ad-Hoc Network Routing (2007)

In recent years, several trust and reputation models have been proposed to enhance the security of mobile ad hoc networks. However, they either fail to capture evidence of trustworthiness within the limitations of the network, or introduce additional problems while capturing the evidence. In this paper, we propose a reputation-based trust model known as secure MANET routing with trust intrigue (SMRTI). In our model, the evidence of trustworthiness is captured in an efficient manner and from broader perspectives including direct interactions with neighbours, observing interactions of neighbours and through recommendations. SMRTI captures evidence from direct interactions with neighbours in order to identify their benign and malicious behaviours. It also captures evidence for misbehaviours by observing the interactions of neighbours. Lastly, the evidence captured from recommendations is used to summarize the benign behaviour of multi-hop nodes. Unlike other models, we adopt a novel approach to capture evidence from recommendations, which eliminates recommender's bias, free-riding, and honest- elicitation. SMRTI utilizes the captured evidence to predict whether a node is either benign or misbehaving. It then applies the prediction to enhance the security of communications depending on the decision policies, such as whether to send a packet to or forward a packet on behalf of other nodes. Finally, we demonstrate the performance of our model through simulation results.
Thiopurine methyltransferase activity in American white subjects and black subjects (1994)

Background Thiopurine methyltransferase (TPMT) is a cytoplasmic enzyme that preferentially catalyzes the S-methylation of aromatic and heterocyclic sulfhydryl compounds, including 6-mercaptopurine. TPMT exhibits genetic polymorphism in white populations, with 89% of individuals having high TPMT activity, 11% having intermediate activity, and one in 300 having extremely low or absent activity. TPMT activity is inversely correlated with formation of active 6-mercaptopurine metabolites (thioguanine nucleotides), thereby influencing 6-mercaptopurine toxicity and efficacy. Methods To investigate ethnic and gender differences in TPMT, we measured erythrocyte TPMT activity in 209 white healthy subjects and 196 black healthy subjects (202 women and 203 men). Results The black population had lower TPMT activity than the white population (median, 14.4 versus 16.8 units/ml packed erythrocytes; p < 0.001). Maximum likelihood estimation of TPMT activity distribution identified 91.9% and 93.9% with high activity and 7.7% and 6.1% with intermediate activity in the white and black groups, respectively. Conclusions These data indicate that TPMT activity is similarly polymorphic in American black subjects and white subjects, although median TPMT activity is approximately 17% lower in black subjects. Clinical Pharmacology and Therapeutics (1994) 55, 15–20; doi:10.1038/clpt.1994.4
Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. (1996)

CDKN2/p16 inhibits the cyclin D/cyclin-dependent kinase complexes that phosphorylate pRb, thus blocking cell cycle progression. We previously reported that p16 levels are low to undetectable in normal human uroepithelial cells (HUCs) and in immortalized uroepithelial cells with functional pRb, whereas p16 levels are markedly elevated in immortal HUCs with altered pRb (T. Yeager et al., Cancer Res., 55: 493-497, 1995). We now report that elevation of p16 levels occurs at senescence in HUCs, including HUCs transformed by human papillomavirus 16 E7 or E6, whose oncoprotein products lead to functional loss of pRb and p53, respectively. We also report that six of six independently immortalized E7 HUCs show high levels of p16 similar to those observed at HUC senescence, whereas p16 is undetectable in five of five immortal E6 HUCs. Four of the five independent E6 HUCs that lost p16 at immortalization showed hemizygous deletion of the 9p21 region. However, no homozygous CDKN2 deletions were detected, and only one CDKN2 mutation was identified. For the first time, these data associate elevated p16 with senescence in human epithelial cells. These data also suggest that a component of immortalization may be abrogation, either by pRb inactivation (as in the E7-transformed HUCs) or by p16 inactivation (as in the E6-transformed HUCs), of a p16-mediated senescence cell cycle block.
Road detection and vehicles tracking by vision for an on-board ACC system in the VELAC vehicle (2000)

The paper presents a method designed to detect and track vehicles on highway in a safety improvement purpose. The goal of this kind of system is to regulate the speed of a vehicle so as to respect safety distances relative to vehicles ahead. The method is exclusively based on monocular computer vision and uses two algorithms. The first one is able to locate the lane borders in the image, and to deduce the 3D shape of the road axis. The second algorithm detects, tracks and computes the 3D location of vehicles ahead by using fixed lights embedded on these vehicles. By combining the results of the two algorithms, a fusion step permits us to know were the most dangerous vehicle is, according to its position, speed and circulation lane. The method has been implemented on our experimental vehicle VELAC and the whole system operates in real time conditions.
ON TYROSINE AND TRYPTOPHANE DETERMINATIONS IN PROTEINS (1927)

The article summarizes research into the existing methods for the quantitative determination of tyrosine and tryptophane in proteins. Limitations to the accuracy of the Folin-Looney method (reaction of a phosphotungstic phosphomolybdic acid in a phenol solution, evaluated using colorimetry) have been solved by an improved method detailed in the text. The hydrolysis of proteinaceous material to allow chemical analysis of tryptophane has also been improved; the method is based on digestion with sodium hydroxide for 18-20 hours, followed by rapid neutralization and acidification with sulfuric acid. A more accurate test for tyrosine based on Millon's reaction has been developed; acidified mercuric sulfate solution is used to dissolve precipitated tyrosine and sodium nitrite is added to produce the colored product which is assessed colorimetrically. Two types of casein analyzed by these methods contained 1.4% tryptophane and 6.37-6.55% tyrosine. Tryptophane and tyrosine content of various materials were: casein 1.4%, 6.4-6.6%; egg albumin 1.3%, 4.0%; edestin 1.5%, 4.5%; gliadin 0.84%, 3.1%; zein 0.17%, 5.9%. A method for preparation of the pure mercuric sulfate reagent is described.
Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice (2008)

The cytotoxic T cell (CT) GalNAc transferase, or Galgt2, is a UDP-GalNAc:beta1,4-N-acetylgalactosaminyltransferase that is localized to the neuromuscular synapse in adult skeletal muscle, where it creates the synaptic CT carbohydrate antigen {GalNAcbeta1,4[NeuAc(orGc)alpha2, 3]Galbeta1,4GlcNAcbeta-}. Overexpression of Galgt2 in the skeletal muscles of transgenic mice inhibits the development of muscular dystrophy in mdx mice, a model for Duchenne muscular dystrophy. Here, we provide physiological evidence as to how Galgt2 may inhibit the development of muscle pathology in mdx animals. Both Galgt2 transgenic wild-type and mdx skeletal muscles showed a marked improvement in normalized isometric force during repetitive eccentric contractions relative to nontransgenic littermates, even using a paradigm where nontransgenic muscles had force reductions of 95% or more. Muscles from Galgt2 transgenic mice, however, showed a significant decrement in normalized specific force and in hindlimb and forelimb grip strength at some ages. Overexpression of Galgt2 in muscles of young adult mdx mice, where Galgt2 has no effect on muscle size, also caused a significant decrease in force drop during eccentric contractions and increased normalized specific force. A comparison of Galgt2 and microdystrophin overexpression using a therapeutically relevant intravascular gene delivery protocol showed Galgt2 was as effective as microdystrophin at preventing loss of force during eccentric contractions. These experiments provide a mechanism to explain why Galgt2 overexpression inhibits muscular dystrophy in mdx muscles. That overexpression also prevents loss of force in nondystrophic muscles suggests that Galgt2 is a therapeutic target with broad potential applications.
Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE (2007)

The four highly conserved Notch receptors receive short-range signals that control many biological processes during development and in adult vertebrate tissues. The involvement of Notch1 signaling in tissue self-renewal is less clear, however. We developed a novel genetic approach N(1)IP-CRE (Notch1 Intramembrane Proteolysis) to follow, at high resolution, the descendents of cells experiencing Notch1 activation in the mouse. By combining N(1)IP-CRE with loss-of-function analysis, Notch activation patterns were correlated with function during development, self-renewal and malignancy in selected tissues. Identification of many known functions of Notch1 throughout development validated the utility of this approach. Importantly, novel roles for Notch1 signaling were identified in heart, vasculature, retina and in the stem cell compartments of self-renewing epithelia. We find that the probability of Notch1 activation in different tissues does not always indicate a requirement for this receptor and that gradients of Notch1 activation are evident within one organ. These findings highlight an underappreciated layer of complexity of Notch signaling in vivo. Moreover, NIP-CRE represents a general strategy applicable for monitoring proteolysis-dependent signaling in vivo.
On the Maximum Common Rate Achievable in a Coordinated Network (2006)

We quantify the ultimate performance limits of inter-cell coordinatation in a cellular downlink network. The goal is to achieve fairness by maximizing the minimum rate in the network subject to per base power constraints. We first solve the max-min rate problem for a particular zero-forcing dirty paper coding scheme so as to obtain an achievable max-min rate, which serves as a lower bound on the ultimate limit. We then obtain a simple upper bound on the max-min rate of any scheme, and show that the rate achievable by the zero-forcing dirty paper coding scheme is close to this upper bound. We also extend our analysis to coordinated networks with multiple antennas.
Etching studies on lutetium yttrium orthosilicate LuxY2-xSiO5:Ce (LYSO) scintillator crystals (2010)

Surface dissolution has been investigated on {100}, {010}, {001}, {110} and {101} oriented Lu1.6Y0.4SiO5:Ce crystal samples by using orthophosphoric acid up to 180°C. Depending on the etching temperature and surface orientation smooth or bunched surfaces were produced. In order to study the effect of the etching process on the scintillation properties temperature dependent optical absorption measurements were carried out up to 236°C. It was found that depending on the post-growth history of the sample, etching may influence the scintillation mechanism by modifying the concentration of shallow traps.
The Measles Virus V Protein Binds to p65 (RelA) To Suppress NF-κB Activity (2011)

Nuclear factor κB (NF-κB) transcription factors are involved in controlling numerous cellular processes, including inflammation, innate and adaptive immunity, and cell survival. Here we show that the immunosuppressive measles virus (MV; Morbillivirus genus, Paramyxoviridae) has evolved multiple functions to interfere with canonical NF-κB signaling in epithelial cells. The MV P, V, and C proteins, also involved in preventing host cell interferon responses, were found to individually suppress NF-κB-dependent reporter gene expression in response to activation of the tumor necrosis factor (TNF) receptor, RIG-I-like receptors, or Toll-like receptors. NF-κB activity was most efficiently suppressed in the presence of V, while expression of P or C resulted in moderate inhibition. As indicated by reporter gene assays involving overexpression of the IκB kinase (IKK) complex, which phosphorylates the inhibitor of κB to liberate NF-κB, V protein targets a downstream step in the signaling cascade. Coimmunoprecipitation experiments revealed that V specifically binds to the Rel homology domain of the NF-κB subunit p65 but not of p50. Notably, the short C-terminal domain of the V protein, which is also involved in binding STAT2, IRF7, and MDA5, was sufficient for the interaction and for preventing reporter gene activity. As observed by confocal microscopy, the presence of V abolished nuclear translocation of p65 upon TNF-α stimulation. Thus, MV V appears to prevent NF-κB-dependent gene expression by retaining p65 in the cytoplasm. These findings reveal NF-κB as a key target of MV and stress the importance of the V protein as the major viral immune-modulatory factor.
Mice Deficient for the Ecto-Nicotinamide Adenine Dinucleotide Glycohydrolase CD38 Exhibit Altered Humoral Immune Responses (1998)

CD38 is a membrane-associated ecto-nicotinamide adenine dinucleotide (NAD+) glycohydrolase that is expressed on multiple hematopoietic cells. The extracellular domain of CD38 can mediate the catalysis of NAD+ to cyclic adenosine diphosphoribose (cADPR), a Ca2+-mobilizing second messenger, adenosine diphosphoribose (ADPR), and nicotinamide. In addition to its enzymatic properties, murine CD38 has been shown to act as a B-cell coreceptor capable of modulating signals through the B-cell antigen receptor. To investigate the in vivo physiological function(s) of this novel class of ectoenzyme we generated mice carrying a null mutation in the CD38 gene. CD38-/- mice showed a complete loss of tissue-associated NAD+ glycohydrolase activity, showing that the classical NAD+ glycohydrolases and CD38 are likely identical. Although murine CD38 is expressed on hematopoietic stem cells as well as on committed progenitors, we show that CD38 is not required for hematopoiesis or lymphopoiesis. However, CD38-/- mice did exhibit marked deficiencies in antibody responses to T-cell-dependent protein antigens and augmented antibody responses to at least one T-cell-independent type 2 polysaccharide antigen. These data suggest that CD38 may play an important role in vivo in regulating humoral immune responses.
Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans (2012)

Avian influenza virus causes outbreaks in domestic and wild birds around the world, and sporadic human infections have been reported. A DNA vaccine encoding hemagglutinin (HA) protein from the A/Indonesia/5/05 (H5N1) strain was initially tested in two randomized phase I clinical studies. Vaccine Research Center study 304 (VRC 304) was a double-blinded study with 45 subjects randomized to placebo, 1 mg of vaccine, or 4 mg of vaccine treatment groups (n = 15/group) by intramuscular (i.m.) Biojector injection. VRC 305 was an open-label study to evaluate route, with 44 subjects randomized to intradermal (i.d.) injections of 0.5 mg by needle/syringe or by Biojector or 1 mg delivered as two 0.5-mg Biojector injections in the same deltoid or as 0.5 mg in each deltoid (n = 11/group). Injections were administered at weeks 0, 4, and 8 in both studies. Antibody responses to H5 were assessed by hemagglutination inhibition (HAI) assay, enzyme-linked immunosorbent assay (ELISA), and neutralization assay, and the H5 T cell responses were assessed by enzyme-linked immunospot and intracellular cytokine staining assays. There were no vaccine-related serious adverse events, and the vaccine was well tolerated in all groups. At 1 mg, i.d. vaccination compared to i.m. vaccination induced a greater frequency and magnitude of response by ELISA, but there were no significant differences in the frequency or magnitude of response between the i.d. and i.m. routes in the HAI or neutralization assays. T cell responses were more common in subjects who received the 1- or 4-mg dose i.m. These studies demonstrated that the DNA vaccine encoding H5 is safe and immunogenic and served to define the proper dose and route for further studies. The i.d. injection route did not offer a significant advantage over the i.m. route, and no difference was detected by delivery to one site versus splitting the dose between two sites for i.d. vaccine administration. The 4-mg dose (i.m) was further investigated in prime-boost regimens.
Synthesis and biological evaluation of two analogues of (S)-α-methyl-3-carboxyphenylalanine (1998)

Two analogues 2, 3 of (S)-alpha-methyl-3-carboxylphenylalanine 1 were synthesized to test their activity for metabotropic glutamate receptors (mGluRs). Both compounds 2 and 3 were inactive as antagonist for mGluRs, but 2 showed weak agonistic activity for GluR6 in contrast to that reported by Kemp and co-workers.
Dendritic Luminescent Gold(III) Complexes for Highly Efficient Solution‐Processable Organic Light‐Emitting Devices (2012)

Emission control: carbazole-based dendritic alkynylgold(III) complexes have been evaluated as phosphorescent emitters in organic light-emitting devices. The energy as well as the bathochromic shift of the emissions can be tuned effectively through a control of the dendrimer generation. The optimized devices show high current and external quantum efficiencies of up to 24.0 cd A(-1) and 7.8 %, respectively.
Transfer hydrogenation of furocoumarin derivatives (1983)

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTTransfer hydrogenation of furocoumarin derivativesNed D. Heindel, Natalie Foster, and Mridula ChoudhuriCite this: J. Org. Chem. 1983, 48, 21, 3817–3819Publication Date (Print):October 1, 1983Publication History Published online1 May 2002Published inissue 1 October 1983https://pubs.acs.org/doi/10.1021/jo00169a045https://doi.org/10.1021/jo00169a045research-articleACS PublicationsRequest reuse permissionsArticle Views223Altmetric-Citations13LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts
[Nasal continuous positive airway pressure and noninvasive positive ventilation in the treatment of sleep apnea/hypopnea syndrome]. (2000)

The main medical treatment of moderate to severe obstructive sleep apnea/hypopnea syndrome is nasal continuous positive airway pressure(nCPAP). When compliance of the patient is low due to nasal or oral dryness, heated humidifier is added to nCPAP. In Japan frequent complaints such as nasal cold and dryness were observed in winter because of infrequent air conditioning in the sleeping room. In the case of dyspnea using nCPAP, bilevel PAP or auto CPAP is recommended. We treated 384 patients with nCPAP and 24% of the patients were added heated humidifier. Auto CPAP and bilevel PAP was administered in 10% and 6% of the patients indicated for PAP treatment, respectively.
Molecular characterization of soybean resistance to soybean cyst nematode (2009)

The entire thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file; a non-technical public abstract appears in the public.pdf file.